Loading stock data...

Tarsons Products Limited

NSE: TARSONS BSE: TARSONS

NSE
185.49 -6.17 (-3.22%)

Prev Close

191.66

Open Price

191.98

Volume

131,882

Today Low / High

184.51 / 192.01

52 WK Low / High

184.51 / 458

Range

176 - 195

BSE
185.75 -5.65 (-2.95%)

Prev Close

191.4

Open Price

191.75

Volume

2,816

Today Low / High

185 / 191.75

52 WK Low / High

185 / 457.25

Range

176 - 195

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 185.49 (target range: 176 - 195), reflecting a change of -6.17 (-3.21924%). On the BSE, it is listed at 185.75 (target range: 176 - 195), showing a change of -5.65 (-2.95193%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

20 Feb 196.00 -0.26%
19 Feb 208.06 -5.50%
18 Feb 203.00 -1.66%
17 Feb 198.00 1.94%
16 Feb 200.45 -1.20%
13 Feb 201.97 -0.75%
12 Feb 209.47 -4.03%
11 Feb 217.05 -3.98%
10 Feb 216.80 0.75%
09 Feb 219.00 -2.46%
06 Feb 206.34 6.16%
05 Feb 206.90 -0.27%
04 Feb 210.00 -1.98%
03 Feb 195.00 4.73%
02 Feb 196.00 -2.24%
01 Feb 196.84 -0.18%
30 Jan 193.50 0.31%
29 Jan 201.50 -3.15%
28 Jan 199.90 -0.42%

Tarsons Products Limited Graph

Tarsons Products Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Tarsons Products Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 185.49, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 185.75 187.61 168.85 - 206.37
189.47 151.57 - 227.36
191.32 133.93 - 248.72
Bearish Scenario 185.75 183.89 165.50 - 202.28
182.04 145.63 - 218.44
180.18 126.12 - 234.23

Overview of Tarsons Products Limited

ISIN

INE144Z01023

Industry

Medical - Instruments & Supplies

Vol.Avg

511,413

Market Cap

10,391,186,679

Last Dividend

2

Official Website

Visit Website

IPO Date

2021-11-26

DCF Diff

1,005.86

DCF

-498

Financial Ratios Every Investor Needs

Stock Dividend of TARSONS

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2024-09-20 September 20, 24 2 2 2024-09-20 2024-10-27

Stock Rating Details for TARSONS

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 392.41 Cr 257.32 Cr 135.09 Cr 0.3443 0.00 Cr 66.44 Cr 48.23 Cr 29.77 Cr 5.60 126.69 Cr 0.0759
2024-03-31 296.39 Cr 197.85 Cr 98.54 Cr 0.3325 0.00 Cr 45.06 Cr 157.00 Cr 42.64 Cr 8.01 111.32 Cr 0.1439
2023-03-31 283.25 Cr 65.05 Cr 218.19 Cr 0.7703 0.00 Cr 3.32 Cr 174.75 Cr 80.71 Cr 15.17 141.70 Cr 0.2850
2022-03-31 300.79 Cr 80.06 Cr 148.89 Cr 0.4950 0.00 Cr 2.67 Cr 132.08 Cr 100.66 Cr 19.46 161.17 Cr 0.3347
2021-03-31 227.91 Cr 74.28 Cr 153.63 Cr 0.6741 0.00 Cr 2.12 Cr 90.86 Cr 68.87 Cr 13.43 108.82 Cr 0.3022

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 25.13 Cr 1,080.04 Cr 449.83 Cr 630.2110 Cr 339.17 Cr 313.51 Cr 126.05 Cr 704.66 Cr 0.00 Cr 52.00 Cr 0.83 Cr 175.7340 Cr
2024-03-31 17.11 Cr 972.18 Cr 359.32 Cr 612.8620 Cr 269.02 Cr 251.91 Cr 133.20 Cr 658.84 Cr 0.82 Cr 24.52 Cr 0.07 Cr 213.1550 Cr
2023-03-31 59.06 Cr 725.68 Cr 156.38 Cr 569.3030 Cr 110.68 Cr 51.63 Cr 119.08 Cr 343.30 Cr 1.55 Cr 7.27 Cr 3.09 Cr 62.9150 Cr
2022-03-31 77.44 Cr 544.23 Cr 54.40 Cr 489.8300 Cr 21.67 Cr -55.78 Cr 87.88 Cr 220.37 Cr 5.00 Cr 5.63 Cr 0.06 Cr 34.9140 Cr
2021-03-31 2.33 Cr 295.95 Cr 51.61 Cr 244.3380 Cr 33.50 Cr 31.17 Cr 56.42 Cr 141.93 Cr 0.25 Cr 3.16 Cr 0.24 Cr 41.7990 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 96.6200 Cr -146.7310 Cr 57.8120 Cr -55.0870 Cr 8.5420 Cr 25.6520 Cr -151.7070 Cr 29.7700 Cr 71.7380 Cr -10.6340 Cr 2.7820 Cr
2024-03-31 102.7050 Cr -284.9560 Cr 135.6250 Cr -81.6280 Cr -41.9480 Cr 17.1100 Cr -184.3330 Cr 60.7680 Cr 145.9610 Cr 0.0000 Cr 7.5150 Cr
2023-03-31 75.5990 Cr -178.5480 Cr 84.5610 Cr -114.3690 Cr -18.3840 Cr 59.0580 Cr -189.9680 Cr 108.7200 Cr 89.0890 Cr 0.0000 Cr -31.9990 Cr
2022-03-31 83.4670 Cr -137.9450 Cr 129.5750 Cr -48.5020 Cr 75.1100 Cr 77.4420 Cr -131.9690 Cr 134.9890 Cr -11.8290 Cr 0.0000 Cr -35.7010 Cr
2021-03-31 68.1550 Cr -63.9110 Cr -27.2230 Cr 3.8330 Cr -22.9790 Cr 2.3320 Cr -64.3220 Cr 92.4340 Cr -0.2610 Cr 0.0000 Cr 2.0310 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 107.89 Cr 79.69 Cr 28.21 Cr 0.2614 6.48 Cr 5.04 Cr 0.95 38.59 Cr 0.0467
2025-09-30 102.33 Cr 73.53 Cr 28.80 Cr 0.2815 4.96 Cr 3.32 Cr 0.62 33.25 Cr 0.0325
2025-06-30 91.36 Cr 29.31 Cr 62.06 Cr 0.6793 4.77 Cr 1.78 Cr 0.34 28.04 Cr 0.0195
2025-03-31 112.69 Cr 74.73 Cr 37.97 Cr 0.3369 17.00 Cr 10.20 Cr 1.92 40.80 Cr 0.0905
2024-12-31 95.68 Cr 31.25 Cr 64.43 Cr 0.6734 12.23 Cr 5.26 Cr 0.99 30.48 Cr 0.0550

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 25.89 Cr 5.46 Cr 31.36 Cr 72.54 Cr 135.38 Cr 254.12 Cr 772.02 Cr 1,163.73 Cr 537.09 Cr
2025-06-30 0.00 Cr 0.00 Cr 25.65 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -630.21 Cr
2025-03-31 25.65 Cr 0.00 Cr 25.65 Cr 79.62 Cr 126.05 Cr 242.58 Cr 704.66 Cr 1,080.04 Cr 449.83 Cr
2024-12-31 0.00 Cr 0.00 Cr 36.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -613.91 Cr
2024-09-30 36.40 Cr 0.00 Cr 36.40 Cr 69.85 Cr 139.36 Cr 262.73 Cr 630.07 Cr 1,054.30 Cr 440.40 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 1.78 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 10.20 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 5.26 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 10.29 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 4.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Instruments & Supplies

Company Name Symbol Price Market Cap Volume
Dr. Agarwal's Health Care Limited AGARWALEYE ₹455.55 ₹144,321,656,625.00 ₹105,883.00
Poly Medicure Limited POLYMED ₹1,287.10 ₹130,459,799,579.00 ₹261,591.00
Shaily Engineering Plastics Limited SHAILY ₹1,945.50 ₹89,405,633,432.00 ₹148,905.00

Key Executives

Whole-time Director
Aryan Sehgal

Gender: male

Year Born: 1988

Vice President of Operations
Lakshmananarayanan Balakrishna Reddy

Gender: male

Year Born:

Chairman, Chief Executive Officer & MD
Sanjive Sehgal

Gender: male

Year Born: 1961

Chief Financial Officer, Company Secretary & Compliance Officer
Santosh Kumar Agarwal

Gender: male

Year Born:

Head of Human Resource
Subhra Sankar Bose

Gender: male

Year Born:

FAQs about Tarsons Products Limited

Who is the CEO of the company?

The CEO is Sanjive Sehgal.

What is the current market price of the stock?

The current price is ₹195.30.

What is the 52-week price range?

The range is ₹188.42-458.

What is the market capitalization of the company?

The market capitalization is ₹1,039.12 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 51.08.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Tarsons Products Limited (ISIN: INE144Z01023) is a leading Medical - Instruments & Supplies in India. With a market capitalization of ₹1,039.12 crores and an average daily volume of 511,413 shares, it operates in the Medical - Instruments & Supplies. The company last declared a dividend of ₹2.